Literature DB >> 4673303

Effect of plasma kallikrein on coagulation in vitro.

K D Wuepper, C G Cochrane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4673303     DOI： 10.3181/00379727-141-36757

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  5 in total

1.  The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.

Authors:  S D Revak; C G Cochrane; J H Griffin
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

2.  Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.

Authors:  C G Cochrane; S D Revak; K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

3.  The autoactivation of rabbit Hageman factor.

Authors:  R C Wiggins; C C Cochrane
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

Review 4.  COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies.

Authors:  Habib Haybar; Mahmood Maniati; Najmaldin Saki; Zeinab Deris Zayeri
Journal:  Mol Biol Rep       Date:  2021-04-10       Impact factor: 2.316

5.  Prekallikrein deficiency in man.

Authors:  K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.